These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4720382)

  • 1. Borderline diabetics and their response to tolbutamide.
    Keen H; Jarrett RJ; Ward JD; Fuller JH
    Adv Metab Disord; 1973; 2():Suppl 2:521-31. PubMed ID: 4720382
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular disease in diabetes and the effect of oral antidiabetic agents.
    Marble A
    Adv Metab Disord; 1973; 2():Suppl 2:539-47. PubMed ID: 4720384
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 4. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
    Meinert CL; Knatterud GL; Prout TE; Klimt CR
    Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventive tolbutamide treatment and arterial disease in mild hyperglycaemia.
    Paasikivi J; Wahlberg F
    Diabetologia; 1971 Oct; 7(5):323-7. PubMed ID: 4943989
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulfonylureas: effects in vivo and in vitro.
    Ann Intern Med; 1971 Oct; 75(4):607-21. PubMed ID: 4328640
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH
    Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress report on the prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes: neurovascular studies.
    Feldman R; Crawford D; Elashoff R; Glass A
    Adv Metab Disord; 1973; 2():Suppl 2:557-67. PubMed ID: 4720386
    [No Abstract]   [Full Text] [Related]  

  • 10. The University Group Diabetes Program. A statistician looks at the mortality results.
    Schor S
    JAMA; 1971 Sep; 217(12):1671-5. PubMed ID: 4937385
    [No Abstract]   [Full Text] [Related]  

  • 11. [Do oral antidiabetics play a part in the cardiovascular mortality of diabetics? Apropos of the University Group Diabetes Program report and the controversies it has raised].
    Canivet J; Deuil R; Eschwege E; Hazard J; Lubetzki J; Tchobroutsky G; Valleron A
    Presse Med (1893); 1971 Dec; 79(53):2437-44. PubMed ID: 5156529
    [No Abstract]   [Full Text] [Related]  

  • 12. The UGDP study.
    Salsburg DS
    JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin-sensitivity and insulin-insensitivity in Indian diabetics as determined by the insulin tolerance test and their influence on the therapeutic response to tolbutamide].
    Singh I; Srivastava MC
    Acta Diabetol Lat; 1970; 7(5):767-76. PubMed ID: 5526500
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents.
    Prout TE
    Med Clin North Am; 1971 Jul; 55(4):1065-75. PubMed ID: 4946757
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide.
    Diabetes; 1976 Dec; 25(12):1129-53. PubMed ID: 992232
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of early diabetes. The University Group Diabetes Program.
    Prout TE
    Adv Metab Disord; 1973; 2():Suppl 2:501-20. PubMed ID: 4720381
    [No Abstract]   [Full Text] [Related]  

  • 18. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
    Kilo C; Miller JP; Williamson JR
    Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of glucose regulation by an intravenous tolbutamide test in coronar insufficiency].
    Cristol R; Cottet J; Cloarec M
    Presse Med (1893); 1970 Mar; 78(16):739-42. PubMed ID: 5445913
    [No Abstract]   [Full Text] [Related]  

  • 20. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
    Cornfield J
    JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.